3M Forecast, price target & analysts
3M Target price 2025 - Analyst rating & recommendation
3M Classifications & Recommendation:
3M Price Target
| Target Price | $152.93 |
| Price | $130.21 |
| Potential | 17.45% |
| Number of Estimates | 15 |
| 15 Analysts have issued a price target 3M 2026 . The average 3M target price is $152.93. This is 17.45% higher than the current stock price. The highest price target is $184.00 41.31% , the lowest is $98.00 24.74% . | |
| A rating was issued by 20 analysts: 11 Analysts recommend 3M to buy, 5 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the 3M stock has an average upside potential 2026 of 17.45% . Most analysts recommend the 3M stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
14 Analysts have issued a sales forecast 3M 2025 . The average 3M sales estimate is $23.8b . This is 10.47% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $24.0b 9.49% , the lowest is $23.4b 11.83% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $24.6b | 0.14% |
|---|---|---|
| 2025 | $23.8b | 3.24% |
| 2026 | $24.5b | 3.07% |
| 2027 | $25.3b | 3.35% |
| 2028 | $26.1b | 2.97% |
| 2029 | $27.5b | 5.57% |
13 Analysts have issued an 3M EBITDA forecast 2025. The average 3M EBITDA estimate is $6.8b . This is 2.08% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.5b 12.31% , the lowest is $6.5b 2.50% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $6.2b | 12.32% |
|---|---|---|
| 2025 | $6.8b | 10.24% |
| 2026 | $7.2b | 6.03% |
| 2027 | $7.6b | 5.18% |
| 2028 | $6.7b | 11.09% |
EBITDA Margin
| 2024 | 25.05% | 12.48% |
|---|---|---|
| 2025 | 28.53% | 13.91% |
| 2026 | 29.35% | 2.87% |
| 2027 | 29.87% | 1.77% |
| 2028 | 25.79% | 13.66% |
4 3M Analysts have issued a net profit forecast 2025. The average 3M net profit estimate is $5.5b . This is 34.40% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $5.8b 42.13% , the lowest is $5.2b 28.87% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $4.1b | 159.78% |
|---|---|---|
| 2025 | $5.5b | 34.40% |
| 2026 | $5.8b | 5.35% |
| 2027 | $5.9b | 2.90% |
Net Margin
| 2024 | 16.57% | 159.86% |
|---|---|---|
| 2025 | 23.02% | 38.89% |
| 2026 | 23.53% | 2.22% |
| 2027 | 23.43% | 0.42% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
4 Analysts have issued a 3M forecast for earnings per share. The average 3M EPS is $10.15 . This is 34.44% higher than earnings per share in the financial year 2024. The highest EPS forecast is $10.73 42.12% , the lowest is $9.73 28.87% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $7.55 | 159.78% |
|---|---|---|
| 2025 | $10.15 | 34.44% |
| 2026 | $10.69 | 5.32% |
| 2027 | $11.00 | 2.90% |
P/E ratio
| Current | 17.28 | 339.00% |
|---|---|---|
| 2025 | 12.86 | 25.58% |
| 2026 | 12.20 | 5.13% |
| 2027 | 11.86 | 2.79% |
Based on analysts' sales estimates for 2025, the 3M stock is valued at an EV/Sales of 3.21 and an P/S ratio of 2.96 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 2.87 | 52.66% |
|---|---|---|
| 2025 | 3.21 | 11.86% |
| 2026 | 3.11 | 2.98% |
| 2027 | 3.01 | 3.24% |
| 2028 | 2.93 | 2.89% |
| 2029 | 2.77 | 5.28% |
P/S ratio
| Current | 2.65 | 71.33% |
|---|---|---|
| 2025 | 2.96 | 11.70% |
| 2026 | 2.87 | 2.98% |
| 2027 | 2.78 | 3.24% |
| 2028 | 2.70 | 2.89% |
| 2029 | 2.56 | 5.28% |
Current 3M Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Apr 14 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 10 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 08 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Mar 06 2025 |
| RBC Capital |
Underperform
➜
Underperform
|
Unchanged | Feb 27 2025 |
| Wells Fargo |
Equal-Weight
➜
Overweight
|
Upgrade | Jan 22 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jan 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Apr 14 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 10 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 08 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Mar 06 2025 |
|
Unchanged
RBC Capital:
Underperform
➜
Underperform
|
Feb 27 2025 |
|
Upgrade
Wells Fargo:
Equal-Weight
➜
Overweight
|
Jan 22 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jan 22 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
